Zhou P P, Clark E, Kapadia M R
Division of Gastrointestinal, Minimally Invasive and Bariatric Surgery, Department of Surgery, University of Iowa Hospital and Clinics, Iowa City, Iowa, USA.
Department of Radiology, University of Iowa Hospital and Clinics, Iowa City, Iowa, USA.
Colorectal Dis. 2016 Nov;18(11):1033-1040. doi: 10.1111/codi.13427.
Presacral masses are uncommon and have malignant potential; treatment typically includes surgical excision. However, there are conditions such as extramedullary haematopoiesis (EMH) which are benign. The present study aimed to summarize the presentation of presacral EMH in our institution, to review the literature and to offer management strategies for this rare condition.
The literature was searched for articles related to presacral EMH, and case reports were collected from articles meeting the inclusion criteria. We collected data on patient demographics, diagnostic investigation, management and the results of treatment.
Thirty-nine patients were included in the systematic review. Initial imaging included computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound (US) suggestive of EMH. Some patients then underwent a technetium scan (n = 7, 18%), biopsy of the presacral lesion (n = 27, 69%) or excision of the entire mass (n = 3, 8%). All patients who underwent technetium scan were confirmed to have EMH, demonstrating enhancement similar to bone marrow. Patients who underwent technetium scan and presacral mass biopsy had concordant results confirming presacral EMH (n = 5, 13%). Data on management were available for 35/39 (90%) with most patients followed by clinical observation (n = 20, 51%). Symptomatic patients were treated with radiotherapy (15%), surgical excision (15%) or hydroxyurea (5%) and blood transfusions (10%). Most (81%, n = 17/21) patients whose outcome was reported remained asymptomatic or experienced pain relief.
Although uncommon, EMH should be considered in the differential diagnosis of a presacral mass. Presacral EMH is a benign condition that can be suspected on CT or MRI and confirmed with technetium scan. Patients may not necessarily need to undergo biopsy to confirm haematopoietic elements. Unlike other presacral masses, patients diagnosed with presacral EMH can be managed by observation. If symptomatic, radiotherapy or surgical excision may be offered.
骶前肿物并不常见且具有恶变潜能;治疗通常包括手术切除。然而,存在诸如髓外造血(EMH)等良性情况。本研究旨在总结我院骶前EMH的表现,回顾相关文献并为这种罕见病症提供管理策略。
检索文献中与骶前EMH相关的文章,并从符合纳入标准的文章中收集病例报告。我们收集了患者人口统计学数据、诊断检查、管理措施及治疗结果。
系统评价纳入了39例患者。初始影像学检查包括计算机断层扫描(CT)、磁共振成像(MRI)或超声(US),提示为EMH。部分患者随后接受了锝扫描(n = 7,18%)、骶前病变活检(n = 27,69%)或整个肿物切除(n = 3,8%)。所有接受锝扫描的患者均确诊为EMH,表现出与骨髓相似的强化。接受锝扫描和骶前肿物活检的患者结果一致,确诊为骶前EMH(n = 5,13%)。35/39(90%)例患者有管理措施数据,大多数患者采取临床观察(n = 20,51%)。有症状的患者接受了放疗(15%)、手术切除(15%)或羟基脲治疗(5%)及输血(10%)。报告了结局的大多数患者(81%,n = 17/21)仍无症状或疼痛缓解。
尽管EMH不常见,但在骶前肿物的鉴别诊断中应予以考虑。骶前EMH是一种良性病症,可通过CT或MRI怀疑,并通过锝扫描确诊。患者不一定需要进行活检来确认造血成分。与其他骶前肿物不同,诊断为骶前EMH的患者可通过观察进行管理。如有症状,可给予放疗或手术切除。